Clinical trials of 18-methoxycoronaridine [18-MC] for obesity and other forms of compulsive behaviour

Trial Profile

Clinical trials of 18-methoxycoronaridine [18-MC] for obesity and other forms of compulsive behaviour

Planning
Phase of Trial: Phase I

Latest Information Update: 10 Jan 2013

At a glance

  • Drugs 18-methoxycoronaridine (Primary)
  • Indications Obesity; Obsessive-compulsive disorders
  • Focus Adverse reactions
  • Sponsors Savant HWP
  • Most Recent Events

    • 10 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top